Romania – Pharmaceutical products – Supply of pharmaceutical products - 36-month Framework Agreement

Opportunity description

This procedure represents the full relaunch, under an accelerated open tender procedure, of the award procedure previously cancelled under number CN1094545, a decision determined exclusively by the technical inability of the electronic platform to process the extension of the deadline for submission of tenders. The contracting authority intends to conclude a framework agreement for the supply of pharmaceutical products (medicinal products for human use) to ensure continuous and specialized medical care for hospitalized patients, with a duration of 36 months, divided into 216 independent lots, with a maximum of 5 economic operators per lot, without reopening competition. The award of the phased subsequent contracts (divided into 4 discrete chronological stages: Stage I - 4 months, Stage II - 12 months, Stage III - 12 months, Stage IV - 8 months) will be made directly by applying the cascade system, in the strict order of the ranking established following the initial procedure, at the firm unit prices tendered in SEAP. Unit prices will be expressed in Lei excluding VAT with 4 decimal places and constitute firm financial ceilings for subsequent contracts, incorporating an asymmetric adjustment mechanism (mandatory automatic reduction upon amendment of CANAMED or an exceptional increase capped by the position above in the cascade upon transition between stages). Deliveries will be made in installments, exclusively on the basis of firm orders issued by the closed-circuit Pharmacy, within a maximum of 3 working days from transmission of the order. Failure to deliver at least 50% of the firm order, without notifying the purchaser thereof before the due date, constitutes a denial of stock and immediately activates the next operator in the cascade. No performance guarantee is required. The number of days before the deadline for submission of tenders by which clarifications may be requested is 6 days. The contracting authority will respond clearly and completely to all requests on the 4th day before the deadline for submission of tenders. The deadlines for receipt of requests for clarification and for transmission of the contracting authority's response were calculated in accordance with the provisions of Art. 161 of Law No. 98/2016 on public procurement, as subsequently amended and supplemented, in relation to the reduction of deadlines in emergency situations provided for by Art. 74 para. (3) of the same legislative act. The emergency situation, determined by the imminent risk of depletion of stocks of essential medicines and the need to ensure continuity of patient treatment, makes compliance with the standard deadline impossible, fully justifying the application of the accelerated procedure with a tender submission period of 15 days. Any request for clarification must be submitted in SEAP (https://e-licitatie.ro/pub). ACENOCUMAROLUM CPR. 2 mg . Quantities are specified in the specifications and in the procedure summary table. ACIDUM ACETYLSALYCILICUM CPR. 75mg. Quantities are specified in the specifications and in the procedure summary table. ACIDUM ASCORBICUM SOL .INJ. 750mg/5ml Quantities are specified in the specifications and in the procedure summary table. ACIDUM URSODEOXYCHOLICUM CAPS. 250mg Quantities are specified in the specifications and in the procedure summary table. ALBUMINUM HUMANUM SOL. PERF. 200g/l Quantities are specified in the specifications and in the procedure summary table. ALLOPURINOLUM COMPR. 200mg. Quantities are specified in the specifications and in the procedure summary table. ALPRAZOLAMUM CPR. 0,25mg. Quantities are specified in the specifications and in the procedure summary table. AMINOPHYLLINUM SOL.INJ. 24mg/ml. Quantities are specified in the specifications and in the procedure summary table. AMIODARONUM CPR. 200mg. Quantities are specified in the specifications and in the procedure summary table. AMIODARONUM CONC. PT. SOL. INJ./PERF. 50mg/ml Quantities are specified in the specifications and in the procedure summary table. AMLODIPINUM CPR. 5mg Quantities are specified in the specifications and in the procedure summary table. AMPICILLINUM PULB.PT.SOL.INJ. 250mg Quantities are specified in the specifications and in the procedure summary table. AMPICILLINUM PULB.PT.SOL.INJ. 500mg Quantities are specified in the specifications and in the procedure summary table. AMPICILLINUM PULB.PT.SOL.INJ. 1g Quantities are specified in the specifications and in the procedure summary table. AQUA AD INJECTABILIA SOLV. PT. UZ PARENT. Quantities are specified in the specifications and in the procedure summary table. APIXABANUM COMPR. FILM. 5 mg Quantities are specified in the specifications and in the procedure summary table. ATORVASTATINUM COMPR. FILM. 40mg Quantities are specified in the specifications and in the procedure summary table. ATRACURIUM SOL. INJ/PERF. 10mg/ml Quantities are specified in the specifications and in the procedure summary table. ATROPINUM SOL.INJ.1mg/ml *1ml. Quantities are specified in the specifications and in the procedure summary table. BENZYLPENICILLINUM PULB.PT.SOL.INJ. 400000 U.I. Quantities are specified in the specifications and in the procedure summary table. BENZYLPENICILLINUM PULB.PT.SOL.INJ. 1000000 U.I. Quantities are specified in the specifications and in the procedure summary table. BILASTINUM COMPR. 20mg. Quantities are specified in the specifications and in the procedure summary table. BROMAZEPAMUM COMPR. 3mg. Quantities are specified in the specifications and in the procedure summary table. BROMHEXINUM COMPR. 12mg. Quantities are specified in the specifications and in the procedure summary table. BUPIVACAINUM Spinal (in NaCl sol.) SOL. INJ. 5mg/ml*4ml Quantities are specified in the specifications and in the procedure summary table. BUTYLSCOPOLAMMONII BROMIDUM SOL. INJ. 20mg/ml Quantities are specified in the specifications and in the procedure summary table. CALCII GLUCONAS SOL.INJ. 94mg/ml Quantities are specified in the specifications and in the procedure summary table. CANDESARTANUM CILEXETIL CPR. 8mg Quantities are specified in the specifications and in the procedure summary table. CAPTOPRILUM CPR. 25mg Quantities are specified in the specifications and in the procedure summary table. CARBAMAZEPINUM COMPR. 200mg Quantities are specified in the specifications and in the procedure summary table. CARBAZOCHROMI SALICYLAS SOL. INJ./PERF. 1,5mg/5ml Quantities are specified in the specifications and in the procedure summary table. CARVEDILOLUM CPR. 6,25mg Quantities are specified in the specifications and in the procedure summary table. CEFIXIMUM 200mg Quantities are specified in the specifications and in the procedure summary table. CEFALEXINUM CPS. 500mg Quantities are specified in the specifications and in the procedure summary table. CEFOTAXIMUM PULB. PT.SOL.INJ./PERF. 1g Quantities are specified in the specifications and in the procedure summary table. CEFUROXIMUM PULB. PT. SUSP. (I.M)/SOL. INJ.(I.M.,I.V.) 750mg Quantities are specified in the specifications and in the procedure summary table. CEFTRIAXONUM SOL.INJ.IM./I.V. PULB. PT. SOL. INJ./PERF. 250mg Quantities are specified in the specifications and in the procedure summary table. CEFTRIAXONUM SOL.INJ.IM./I.V. PULB. PT. SOL. INJ./PERF. 1g Quantities are specified in the specifications and in the procedure summary table. CHLORZOXAZONUM CPR. 250mg Quantities are specified in the specifications and in the procedure summary table. CIPROFLOXACINUM CPR. FILM. 250mg Quantities are specified in the specifications and in the procedure summary table. CIPROFLOXACINUM CPR. FILM. 500mg Quantities are specified in the specifications and in the procedure summary table. CIPROFLOXACINUM CONC. PT. SOL. PERF.100mg/10ml Quantities are specified in the specifications and in the procedure summary table. CLINDAMYCINUM SOL. INJ./PERF. 150mg/ml vial containing 4 ml sol. inj./perf. Quantities are specified in the specifications and in the procedure summary table. CLINDAMYCINUM COMPR. FILM. 600mg Quantities are specified in the specifications and in the procedure summary table. CLOPIDOGRELUM COMPR. FILM. 75mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (LIDOCAINUM+CHLORHEXIDINUM) 20mg+0,5mg/g(single-dose PP syringes for urethral administration containing 12.5g gel) Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(AMOXICILLINUM + ACIDUM CLAVULANICUM) PULB. PT. SOL. INJ./ PERF.1000mg/200mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(AMPICILLINUM + SULBACTAMUM) PULB. PT. SOL. INJ./ PERF.1000mg/500mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(BETHAMETASONUM+CLORAMPHENICOLUM) EYE DROPS SUSP. 2mg/5mg/ml Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(calcium carbonate, magnesium carbonate, magnesium trisilicate) CHEWABLE CPR. Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(CEFOPERAZONUM + SULBACTAMUM) PULB. PT. SOL. INJ./ PERF.1000mg/1000mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(oxytetracycline hydrochloride, hydrocortisone and excipients: sorbitan trioleate isopropyl myristate, norflurane) cutaneous spray, 59,5 g Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(L-arginine hydrochloride, sorbitol) 50g/l+100g/l - PERF. VIAL * 250ml Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(L-arginine hydrochloride, sorbitol) 50g/l+100g/l - PERF. VIAL * 500ml Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(pyridoxine hydrochloride, D, L-aspartic acid) CONC. PT. SOL. PERF.* 10ml. Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(sodium chloride, calcium chloride dihydrate, potassium chloride) SOL.PERF.* 500ml LDPE Ecoflac plus vial (pack of 10 vials) Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (CHLORAMPHENICOLUM+METRONIDAZOLUM+NYSTATINUM+HYDROCORTISONUM) OVULES. Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (DICLOFENACUM+MISOPROSTOLUM ) GASTRO-RESISTANT COMPR.75 mg/0,200 mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (Hederae folium 0,7 g dry extract (5 -7,5):1 / ethanolum 30% (m/m). /100 ml syrup (the dry extract from ivy leaves (Hederae folium) 100 ml syrup contains 0,7 g dry extract from ivy leaves (Hederae folium) (5 -7,5):1. Extraction agent: ethyl alcohol (ethanol) 30% (m/m). Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (Iron/Qfer 30mg + Vitamin C 66mg) QuattroFerrin/ micronized and microencapsulated ferric pyrophosphate 30mg - 214%NRV* + Vitamin C 66mg - 82%NRV) Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (Inulin 1000 mg Saccharomyces boulardii - 250 mg) SACHET Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(METAMIZOLUM NATRIUM+PITOFENONI HYDROCHLORIDUM+FENPIVERINI BROMIDUM) 500mg/2mg/0,02mg/ml SOL.INJ.*5ml Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (METRONIDAZOLUM+CLOTRIMAZOLUM) 500mg/200mg OVULES Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (METRONIDAZOLUM+CLOTRIMAZOLUM) VAGINAL CREAM 200mg/g+40mg/g Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (OLMESARTANUM MEDOXOMILUM+AMLODIPINUM) COMPR. FILM. 20mg/5mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(OLMESARTANUM MEDOXOMILUM+AMLODIPINUM) COMPR. FILM. 40mg/5mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(OLMESARTANUM MEDOXOMILUM+AMLODIPINUM) COMPR. FILM. 40mg/10mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (PARACETAMOLUM+IBUPROFENUM) SOL. PERF. 1000mg/300mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (PERINDOPRILUM+INDAPAMIDUM) COMPR. 4mg/1,25mg. Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (PERINDOPRILUM+INDAPAMIDUM+AMLODIPINUM) COMPR. FILM. 5mg/1,25mg/5mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (PERINDOPRILUM+INDAPAMIDUM+AMLODIPINUM) COMPR. FILM. 10mg/2,5mg/5mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (TETRACYCLINUM+HYDROCORTISONUM+BENZOCAINUM) 10 mg/5 mg/4 mg/g OINTMENT * Al tube x 18 g Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (TRIAMCINOLONUM+NEOMICINUM+NYSTATINUM) CREAM * Al tube of 15 g Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(Saccharomyces boulardii SB01 -125mg/1 billion CFU*Lactobacillus bulgaricus LB42-10 mg/100 million CFU*Lactobacillus rhamnosus LRa05 -7,5 mg/500 million CFU* FOS/fructo-oligosaccharides - 45 mg Terminalia chebula extract -25 mg Mentha piperita extract 20 mg) GASTRO-RESISTANT CAPSULES Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(NA SULFATE + MG SULFATE + K SULFATE) CONC. PT. ORAL SOL. vial x 176 ml conc. pt. oral sol. Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(zinc bacitracin, neomycin in the form of neomycin sulfate) POWDER vial* 10g Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (zinc bacitracin, neomycin in the form of neomycin sulfate) OINTMENT Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS PANCREATIN (pancreatin 275 mg -amylase, lipase, protease) GASTRO-RESISTANT CPR. 275mg Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS(AMINO ACIDS) SOL. PERF. 5%* 500ml Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (Simethiconum+Charcoal) CPR. 50mg simethicone +300mg charcoal Quantities are specified in the specifications and in the procedure summary table. COMBINATIONS (SPIRONOLACTONUM+FUROSEMIDUM) 50mg/20mg capsules Quantities are specified in the specifications and in the procedure summary table. IRON (III) HYDROXIDE SUCROSE COMPLEX SOL. INJ./PERF. 100mg/5 ml Quantities are specified in the specifications and in the procedure summary table. DESLORATADINUM COMPR. FILM. 5mg Quantities are specified in the specifications and in the procedure summary table. DESLORATADINUM ORAL SOL. 0.5mg/ml * 120ml Quantities are specified in the specifications and in the procedure summary table. DEXAMETHASONUM SOL.INJ. 4mg/ml Quantities are specified in the specifications and in the procedure summary table. DEXKETOPROFENUM SOL.INJ./CONC. PT. SOL. PERF. 50mg/2ml Quantities are specified in the specifications and in the procedure summary table. DIAZEPAMUM RECTAL SOL. 5mg/2.5ml Quantities are specified in the specifications and in the procedure summary table. DIAZEPAMUM CPR. 10mg Quantities are specified in the specifications and in the procedure summary table. DIAZEPAMUM SOL.INJ. 5mg/ml*2ml Quantities are specified in the specifications and in the procedure summary table. DICLOFENACUM PROLONGED-RELEASE CAPS. 150mg Quantities are specified in the specifications and in the procedure summary table. DICLOFENACUM SOL. INJ./PERF. 25mg/ml*3ml Quantities are specified in the specifications and in the procedure summary table. DIGOXINUM CPR. 0,25mg Quantities are specified in the specifications and in the procedure summary table. DIGOXINUM SOL. INJ. 0,5mg/2ml Quantities are specified in the specifications and in the procedure summary table. DIOSMECTITE SACHET. 3g Quantities are specified in the specifications and in the procedure summary table. DIOSMINUM (COMBINATIONS) COMPR. FILM. 500mg Quantities are specified in the specifications and in the procedure summary table. DOPAMINUM CONC. PT. SOL. PERF. 5mg/ml Quantities are specified in the specifications and in the procedure summary table. DYDROGESTERONUM COMPR. FILM. 10mg Quantities are specified in the specifications and in the procedure summary table. DROTAVERINUM SOL.INJ. 40mg/2ml Quantities are specified in the specifications and in the procedure summary table. EDOXABANUM COMPR. FILM. 30mg Quantities are specified in the specifications and in the procedure summary table. EDOXABANUM COMPR. FILM. 600mg Quantities are specified in the specifications and in the procedure summary table. ENALAPRILUM SOL. INJ./PERF 1.25mg/ml Quantities are specified in the specifications and in the procedure summary table. ENOXAPARINUM SOL. INJ. IN PRE-FILLED SYRINGE 4000UI(40mg)/0,4ml Quantities are specified in the specifications and in the procedure summary table. ENOXAPARINUM SOL. INJ. IN PRE-FILLED SYRINGE 6000UI(60mg)/0,6ml Quantities are specified in the specifications and in the procedure summary table. EPHEDRINI HYDROCHLORIDUM SOL.INJ. 50mg/ml *1ml Quantities are specified in the specifications and in the procedure summary table. EPINEPHRINUM SOL. INJ. 1mg/ml * 1ml Quantities are specified in the specifications and in the procedure summary table. ERDOSTEINUM PULB. PT. ORAL SUSP. 175mg/5ml Quantities are specified in the specifications and in the procedure summary table. ERDOSTEINUM CAPS. 300mg Quantities are specified in the specifications and in the procedure summary table. ESOMEPRAZOLUM GASTRO-RESISTANT COMPR. 40mg Quantities are specified in the specifications and in the procedure summary table. ESOMEPRAZOLUM PULB. PT. SOL. INJ./PERF. 40mg Quantities are specified in the specifications and in the procedure summary table. ETAMSYLATUM SOL. INJ. 250mg/2ml Quantities are specified in the specifications and in the procedure summary table. ETORICOXIBUM COMPR. FILM. 60mg Quantities are specified in the specifications and in the procedure summary table. FENTANILUM SOL. INJ. 50micrograms/ml * 10ML Quantities are specified in the specifications and in the procedure summary table. FLUTICASONUM PROPIONAT PRESSURIZED INHALATION SUSP. 125 µg/dose CFC-Free INHALER Quantities are specified in the specifications and in the procedure summary table. FURAZOLIDONUM COMPR. 100mg Quantities are specified in the specifications and in the procedure summary table. FUROSEMIDUM CPR. 40mg Quantities are specified in the specifications and in the procedure summary table. FUROSEMIDUM SOL. INJ. 10mg/ml * 2ml Quantities are specified in the specifications and in the procedure summary table. GABAPENTINUM CPS. 300mg Quantities are specified in the specifications and in the procedure summary table. GENTAMICINUM SOL.INJ. 80mg/2ml Quantities are specified in the specifications and in the procedure summary table. GLUCOSUM 5% SOL.PERF. 50mg/ml 500ml vial (pack of 10 vials) Quantities are specified in the specifications and in the procedure summary table. GLUCOSUM 10% SOL.PERF.100mg/ml x 500ml Quantities are specified in the specifications and in the procedure summary table. GLUCOSUM 33% SOL.INJ. 3,3g/10ml Quantities are specified in the specifications and in the procedure summary table. HALOPERIDOLUM ORAL DROPS SOL. 2mg/ml*10ml Quantities are specified in the specifications and in the procedure summary table. HYDROCORTISONUM PULB.+SOLVENT PT. SOL.INJ.100mg (1vial+1ampoule) Quantities are specified in the specifications and in the procedure summary table. HYDROCORTISONUM SOL.INJ. 19.6mg/5ml Quantities are specified in the specifications and in the procedure summary table. IBUPROFENUM COMPR. FILM. 400mg Quantities are specified in the specifications and in the procedure summary table. IBUPROFENUM ORAL SUSP. 100mg/5ml*100ml Quantities are specified in the specifications and in the procedure summary table. INDOMETACINUM SUPPOSITORIES 50mg Quantities are specified in the specifications and in the procedure summary table. INSULINUM ASPART SOL. INJ.- FLEXPEN 100 units/ml pre-filled injector pens (pens) x 3ml Quantities are specified in the specifications and in the procedure summary table. IVABRADINUM COMPR. FILM. 5mg Quantities are specified in the specifications and in the procedure summary table. KALII CHLORIDUM CONC. PT. SOL. PERF. 74,56 mg/ml * 20ml MPC Quantities are specified in the specifications and in the procedure summary table. KETOPROFENUM SOL.INJ.100mg/2ml Quantities are specified in the specifications and in the procedure summary table. KETOROLACUM TROMETHAMIN SOL. INJ. 30mg/ml Quantities are specified in the specifications and in the procedure summary table. KETOTIFENUM COMPR. 1mg Quantities are specified in the specifications and in the procedure summary table. LACTULOSUM 66.7% x 200ml Quantities are specified in the specifications and in the procedure summary table. LERCANIDIPINUM COMPR. FILM. 10mg Quantities are specified in the specifications and in the procedure summary table. LEVOFLOXACINUM COMPR. FILM. 500mg Quantities are specified in the specifications and in the procedure summary table. LIDOCAINUM SOL. INJ. 10mg/ml* 10ml Quantities are specified in the specifications and in the procedure summary table. LIDOCAINUM SOL. INJ.80mg/2ml Quantities are specified in the specifications and in the procedure summary table. LIDOCAINUM SPRAY - SOL. 4,6mg/dose Quantities are specified in the specifications and in the procedure summary table. Lynside PRO SCB Saccharomyces cerevisiae var. boulardii - 250 mg equivalent to 5 billion CFU, lactose monohydrate, magnesium salts of vegetable fatty acids, gelatin, calcium carbonate, starch sodium octenyl succinate CAPSULES 250 mg Quantities are specified in the specifications and in the procedure summary table. Lynside PRO SCB Saccharomyces cerevisiae var. boulardii - 250 mg equivalent to 5 billion CFU, natural orange flavor, magnesium salts of fatty acids /vegetable source, steviol glycosides from stevia, fructose SACHET 250 mg* 2g Quantities are specified in the specifications and in the procedure summary table. LORAZEPAMUM COMPR. 1mg Quantities are specified in the specifications and in the procedure summary table. MANNITOLUM 20% SOL.PERF. 200 mg/ml x 250ml Quantities are specified in the specifications and in the procedure summary table. MEBEVERINUM DRAJ. 100mg Quantities are specified in the specifications and in the procedure summary table. MEROPENEMUM PULB. PT. SOL. INJ. /PERF. 1000mg Quantities are specified in the specifications and in the procedure summary table. METAMIZOLUM NATRIUM SOL.INJ. 1g/2ml Quantities are specified in the specifications and in the procedure summary table. METAMIZOLUM NATRIUM CPR. 500mg Quantities are specified in the specifications and in the procedure summary table. METHYLPREDNISOLONUM PULB. + SOLV. PT. SOL. INJ./PERF. 500mg 1 lyoph. vial + 1 solvent ampoule. Quantities are specified in the specifications and in the procedure summary table. METOCLOPRAMIDUM SOL.INJ. 5mg/ml Quantities are specified in the specifications and in the procedure summary table. METOPROLOLUM SOL. INJ. I.V/PERF. 5mg/5ml Quantities are specified in the specifications and in the procedure summary table. METOPROLOLUM CPR. 50mg Quantities are specified in the specifications and in the procedure summary table. METRONIDAZOLUM CPR. 250mg Quantities are specified in the specifications and in the procedure summary table. METRONIDAZOLUM SOL. PERF. 5g/l (in NaCl sol.) x 200ml Quantities are specified in the specifications and in the procedure summary table. METRONIDAZOLUM SOL. PERF. 5g/l (in Glucose sol.) x 200mlQuantities are specified in the specifications and in the procedure summary table. MORPHYNUM SOL. INJ. 20mg/ml Quantities are specified in the specifications and in the procedure summary table. MOXIFLOXACINUM SOL. PERF. 400mg/250ml Quantities are specified in the specifications and in the procedure summary table. NALOXONUM SOL. INJ. 0.4mg/ml Quantities are specified in the specifications and in the procedure summary table. NATRII CHLORIDUM 0,9% SOL.PERF. 9mg/ml * 500ml (pack of 10 vials) Quantities are specified in the specifications and in the procedure summary table. NATRII CHLORIDUM 0,9% SOL.PERF. 9mg/ml * 250ml (pack of 10 vials) Quantities are specified in the specifications and in the procedure summary table. NATRII CHLORIDUM CONC. PT. SOL. PERF. 58,5mg/ml one-piece PE vial x 20 ml Quantities are specified in the specifications and in the procedure summary table. NEBIVOLOLUM CPR. 5mg Quantities are specified in the specifications and in the procedure summary table. NEOSTIGMINI METILSULFAS SOL.INJ. 0,5mg/ml Quantities are specified in the specifications and in the procedure summary table. NITROGLYCERINUM SUBLINGUAL COMPR. 0,5mg Quantities are specified in the specifications and in the procedure summary table. NITROGLYCERINUM PROLONGED-RELEASE COMPR. 2.6mg Quantities are specified in the specifications and in the procedure summary table. NITROGLYCERINUM SOL. PERF. 1mg/ml Quantities are specified in the specifications and in the procedure summary table. NITROGLYCERINUM SUBLINGUAL SPRAY 0.4mg/dose Quantities are specified in the specifications and in the procedure summary table. OMEPRAZOLUM GASTRO-RESISTANT CAPS. 20mg Quantities are specified in the specifications and in the procedure summary table. OXACILLINUM PULB. PT. SOL. INJ./PERF. 1000mg Quantities are specified in the specifications and in the procedure summary table. PANTOPRAZOLUM PULB. PT. SOL. INJ. 40mg Quantities are specified in the specifications and in the procedure summary table. PANTOPRAZOLUM GASTRO-RESISTANT COMPR. 20mg Quantities are specified in the specifications and in the procedure summary table. PARACETAMOLUM SUP. 125mg Quantities are specified in the specifications and in the procedure summary table. PARACETAMOLUM SUP. 250mg Quantities are specified in the specifications and in the procedure summary table. PARACETAMOLUM SOL. PERF. 10mg/ml * 100ml Quantities are specified in the specifications and in the procedure summary table. PARACETAMOLUM ORAL SUSPENSION 120mg/5ml * 100ml Quantities are specified in the specifications and in the procedure summary table. PARACETAMOLUM CPR. 500mg Quantities are specified in the specifications and in the procedure summary table. PENTAERITHRITYLI TETRANITRAS CPR. 20mg Quantities are specified in the specifications and in the procedure summary table. PENTOXIPHYLLINUM PROLONGED-RELEASE CPR. 400mg Quantities are specified in the specifications and in the procedure summary table. PENTOXIPHYLLINUM SOL. PERF. 100mg /5ml Quantities are specified in the specifications and in the procedure summary table. PETHIDINUM SOL. INJ. 50mg/ml Quantities are specified in the specifications and in the procedure summary table. PHENOBARBITALUM CPR. 100mg Quantities are specified in the specifications and in the procedure summary table. PHENOBARBITALUM SOL. INJ. 100mg/ml*2ml Quantities are specified in the specifications and in the procedure summary table. PHYTOMENADIONUM SOL.INJ. 10mg/ml *1ml Quantities are specified in the specifications and in the procedure summary table. PIRACETAMUM COMPR. FILM. 800mg Quantities are specified in the specifications and in the procedure summary table. PIRACETAMUM SOL. INJ. 1g/5ml Quantities are specified in the specifications and in the procedure summary table. POVIDONUM IODINATUM EXTERNAL SOL. 10% * 1000ml Quantities are specified in the specifications and in the procedure summary table. PROGESTERONUM SOFT CAPS. 200mg Quantities are specified in the specifications and in the procedure summary table. PROPOFOLUM EMULSION PERF. / INJ. 10mg/ml *20ml Quantities are specified in the specifications and in the procedure summary table. PROPOFOLUM EMULSION PERF. / INJ. 10mg/ml *50ml Quantities are specified in the specifications and in the procedure summary table. PROPRANOLOLUM CPR. 10mg Quantities are specified in the specifications and in the procedure summary table. PYRIDOXINUM SOL. INJ. 50mg/ml * 2ml Quantities are specified in the specifications and in the procedure summary table. RACECADOTRILUM ORAL POWDER 30mg Quantities are specified in the specifications and in the procedure summary table. RIFAXIMINUM COMPR. FILM. 400 mg Quantities are specified in the specifications and in the procedure summary table. RILMENIDINUM COMPR. 1mg Quantities are specified in the specifications and in the procedure summary table. RIVAROXABANUM COMPR. FILM. 15mg Quantities are specified in the specifications and in the procedure summary table. ROSUVASTATINUM COMPR. FILM./ CAPS. 20mg Quantities are specified in the specifications and in the procedure summary table. SALBUTAMOLUM PRESSURIZED INHALATION SUSP. 100µg/dose Quantities are specified in the specifications and in the procedure summary table. SEVOFLURANE INHALATION VAPOR, LIQUID* 250ml (379,25g) Quantities are specified in the specifications and in the procedure summary table. SILIBINUM CPR. 35mg Quantities are specified in the specifications and in the procedure summary table. SIMETHICONUM ORAL DROPS, 100mg/ml Quantities are specified in the specifications and in the procedure summary table. SIMVASTATINUM COMPR. 20mg Quantities are specified in the specifications and in the procedure summary table. SPIRONOLACTONUM CPR. 25mg Quantities are specified in the specifications and in the procedure summary table. SUCRALFATUM COMPR . 1g Quantities are specified in the specifications and in the procedure summary table. SULODEXIDUM 250ULS Quantities are specified in the specifications and in the procedure summary table. SULODEXIDUM 600ULS/2 ml Quantities are specified in the specifications and in the procedure summary table. SUXAMETHONII CHLORIDUM SOL.INJ. 0.1g/5ml Quantities are specified in the specifications and in the procedure summary table. TAMSULOSINUM PROLONGED-RELEASE COMPR. 0,4mg Quantities are specified in the specifications and in the procedure summary table. TETRACYCLINUM OINT. 30mg/g *12g Quantities are specified in the specifications and in the procedure summary table. THIAMINUM SOL. INJ. 100mg/2ml Quantities are specified in the specifications and in the procedure summary table. TIANEPTINUM DRAJ. 12.5mg Quantities are specified in the specifications and in the procedure summary table. TIAPRIDUM COMPR. 100mg Quantities are specified in the specifications and in the procedure summary table. TOLPERISONUM CPR. FILM. 150mg Quantities are specified in the specifications and in the procedure summary table. TROSPIUM COMPR. FILM. 30mg Quantities are specified in the specifications and in the procedure summary table. TRIMEBUTINUM GRAN. PT. ORAL SUSP. 24mg/5ml*125ml Quantities are specified in the specifications and in the procedure summary table. TRIMEBUTINUM COMPR./COMPR. FILM. 100mg Quantities are specified in the specifications and in the procedure summary table. TRIMETAZIDINUM MODIFIED-RELEASE COMPR./PROLONGED-RELEASE COMPR. 35mg Quantities are specified in the specifications and in the procedure summary table. ADSORBED TETANUS VACCINE 0.5ml/dose susp.inj. Quantities are specified in the specifications and in the procedure summary table. Procedure: open. Estimated value: 7,950,561.71 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.